The rounds this investor is named on, who it invests beside, and where it shows up.
Named on 3 rounds in the feed, most often in Medtech.
We invest in early & late stage companies taking novel scientific approaches to address significant unmet needs in the life sciences and information technology sectors
Venture capitalGreenwich, CT, USAnewscienceventures.comRounds from 2016-03-14 to 2026-10-22
| Company | Round | Amount | Announced | Role |
|---|---|---|---|---|
Promaxo A minimally-invasive and patient-centric MRI and robotic platform | Series C Developing, 6 sources | $100M incl. grants | 2026-10-22 | [ PART ] |
Cambridge Epigenetix A DNA sequencing technology platform | Series D |
| $88M |
| 2021-11-02 |
| [ PART ] |
Cambridge Epigenetix A DNA sequencing technology platform | Series B Developing, 2 sources[ HISTORY ]: An earlier round, from the company's own announcement, found while researching the company. Checked like any round, but not new, so it stays out of the daily feed and alerts; a date range shows it. | $21M | 2016-03-14 | [ PART ] |